Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 176

1.

Role of dopamine transporters in the behavioral effects of 3,4-methylenedioxymethamphetamine (MDMA) in nonhuman primates.

Fantegrossi WE, Bauzo RM, Manvich DM, Morales JC, Votaw JR, Goodman MM, Howell LL.

Psychopharmacology (Berl). 2009 Aug;205(2):337-47. doi: 10.1007/s00213-009-1545-0. Epub 2009 May 7.

2.

The neuropharmacology of prolactin secretion elicited by 3,4-methylenedioxymethamphetamine ("ecstasy"): a concurrent microdialysis and plasma analysis study.

Murnane KS, Kimmel HL, Rice KC, Howell LL.

Horm Behav. 2012 Feb;61(2):181-90. doi: 10.1016/j.yhbeh.2011.10.012. Epub 2011 Dec 14.

3.

Faster onset and dopamine transporter selectivity predict stimulant and reinforcing effects of cocaine analogs in squirrel monkeys.

Kimmel HL, O'Connor JA, Carroll FI, Howell LL.

Pharmacol Biochem Behav. 2007 Jan;86(1):45-54. Epub 2006 Dec 20.

4.

In vivo pharmacology of MDMA and its enantiomers in rhesus monkeys.

Fantegrossi WE.

Exp Clin Psychopharmacol. 2008 Feb;16(1):1-12. doi: 10.1037/1064-1297.16.1.1.

PMID:
18266547
5.

Interaction of cocaine and dopamine transporter inhibitors on behavior and neurochemistry in monkeys.

Ginsburg BC, Kimmel HL, Carroll FI, Goodman MM, Howell LL.

Pharmacol Biochem Behav. 2005 Mar;80(3):481-91.

PMID:
15740791
6.

Reinforcing and discriminative stimulus effects of RTI 111, a 3-phenyltropane analog, in rhesus monkeys: interaction with methamphetamine.

Ranaldi R, Anderson KG, Carroll FI, Woolverton WL.

Psychopharmacology (Berl). 2000 Dec;153(1):103-10.

PMID:
11255920
7.

Pizotyline effectively attenuates the stimulus effects of N-methyl-3,4-methylenedioxyamphetamine (MDMA).

Young R, Khorana N, Bondareva T, Glennon RA.

Pharmacol Biochem Behav. 2005 Oct;82(2):404-10. Epub 2005 Oct 25.

PMID:
16253319
8.

3,4-methylenedioxymethamphetamine self-administration is abolished in serotonin transporter knockout mice.

Trigo JM, Renoir T, Lanfumey L, Hamon M, Lesch KP, Robledo P, Maldonado R.

Biol Psychiatry. 2007 Sep 15;62(6):669-79. Epub 2007 Feb 16.

PMID:
17306775
9.

Behavioral and neurochemical consequences of long-term intravenous self-administration of MDMA and its enantiomers by rhesus monkeys.

Fantegrossi WE, Woolverton WL, Kilbourn M, Sherman P, Yuan J, Hatzidimitriou G, Ricaurte GA, Woods JH, Winger G.

Neuropsychopharmacology. 2004 Jul;29(7):1270-81.

10.
11.

Discriminative stimulus effects of psychostimulants and hallucinogens in S(+)-3,4-methylenedioxymethamphetamine (MDMA) and R(-)-MDMA trained mice.

Murnane KS, Murai N, Howell LL, Fantegrossi WE.

J Pharmacol Exp Ther. 2009 Nov;331(2):717-23. doi: 10.1124/jpet.109.156174. Epub 2009 Aug 14.

12.

Interactions between 3,4-methylenedioxymethamphetamine and sigma1 receptors.

Brammer MK, Gilmore DL, Matsumoto RR.

Eur J Pharmacol. 2006 Dec 28;553(1-3):141-5. Epub 2006 Sep 28.

13.

Endocrine and neurochemical effects of 3,4-methylenedioxymethamphetamine and its stereoisomers in rhesus monkeys.

Murnane KS, Fantegrossi WE, Godfrey JR, Banks ML, Howell LL.

J Pharmacol Exp Ther. 2010 Aug;334(2):642-50. doi: 10.1124/jpet.110.166595. Epub 2010 May 13.

14.

Self-administration of cocaine and the cocaine analog RTI-113: relationship to dopamine transporter occupancy determined by PET neuroimaging in rhesus monkeys.

Wilcox KM, Lindsey KP, Votaw JR, Goodman MM, Martarello L, Carroll FI, Howell LL.

Synapse. 2002 Jan;43(1):78-85.

PMID:
11746736
15.

Pharmacological characterization of the effects of 3,4-methylenedioxymethamphetamine ("ecstasy") and its enantiomers on lethality, core temperature, and locomotor activity in singly housed and crowded mice.

Fantegrossi WE, Godlewski T, Karabenick RL, Stephens JM, Ullrich T, Rice KC, Woods JH.

Psychopharmacology (Berl). 2003 Mar;166(3):202-11. Epub 2003 Feb 1.

16.

Effects of histamine H(3) receptor activation on the behavioral-stimulant effects of methamphetamine and cocaine in mice and squirrel monkeys.

Banks ML, Manvich DF, Bauzo RM, Howell LL.

Pharmacology. 2009;83(3):164-9. doi: 10.1159/000191473. Epub 2009 Jan 15.

17.

3,4-Methylenedioxymethamphetamine (MDMA, "ecstasy") and its stereoisomers as reinforcers in rhesus monkeys: serotonergic involvement.

Fantegrossi WE, Ullrich T, Rice KC, Woods JH, Winger G.

Psychopharmacology (Berl). 2002 Jun;161(4):356-64. Epub 2002 Apr 19.

18.

Effects of dopamine transporter inhibitors on cocaine self-administration in rhesus monkeys: relationship to transporter occupancy determined by positron emission tomography neuroimaging.

Lindsey KP, Wilcox KM, Votaw JR, Goodman MM, Plisson C, Carroll FI, Rice KC, Howell LL.

J Pharmacol Exp Ther. 2004 Jun;309(3):959-69. Epub 2004 Feb 24.

19.

A reliable model of intravenous MDMA self-administration in naïve mice.

Trigo JM, Panayi F, Soria G, Maldonado R, Robledo P.

Psychopharmacology (Berl). 2006 Jan;184(2):212-20. Epub 2005 Dec 15.

PMID:
16362403
20.

Effects of combined dopamine and serotonin transporter inhibitors on cocaine self-administration in rhesus monkeys.

Howell LL, Carroll FI, Votaw JR, Goodman MM, Kimmel HL.

J Pharmacol Exp Ther. 2007 Feb;320(2):757-65. Epub 2006 Nov 14.

Supplemental Content

Support Center